These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17166507)

  • 1. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.
    Luque-Garcia JL; Neubert TA
    J Chromatogr A; 2007 Jun; 1153(1-2):259-76. PubMed ID: 17166507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Sampling and Preparation Procedures for Proteomic Biomarker Studies of Psychiatric Disorders.
    Guest PC; Rahmoune H
    Adv Exp Med Biol; 2017; 974():141-147. PubMed ID: 28353230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
    Metzger J; Luppa PB; Good DM; Mischak H
    Crit Rev Clin Lab Sci; 2009; 46(3):129-52. PubMed ID: 19404829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine proteomic analysis: use of two-dimensional gel electrophoresis, isotope coded affinity tags, and capillary electrophoresis.
    Sobhani K
    Methods Mol Biol; 2010; 641():325-46. PubMed ID: 20407955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in sample preparation for classical and second generation proteomics.
    Cañas B; Piñeiro C; Calvo E; López-Ferrer D; Gallardo JM
    J Chromatogr A; 2007 Jun; 1153(1-2):235-58. PubMed ID: 17276441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids for in-depth proteomics analysis.
    Jmeian Y; El Rassi Z
    Electrophoresis; 2009 Jan; 30(1):249-61. PubMed ID: 19101934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines.
    Aguilar-Mahecha A; Kuzyk MA; Domanski D; Borchers CH; Basik M
    PLoS One; 2012; 7(6):e38290. PubMed ID: 22701622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system.
    Wu SL; Amato H; Biringer R; Choudhary G; Shieh P; Hancock WS
    J Proteome Res; 2002; 1(5):459-65. PubMed ID: 12645918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current two-dimensional electrophoresis technology for proteomics.
    Görg A; Weiss W; Dunn MJ
    Proteomics; 2004 Dec; 4(12):3665-85. PubMed ID: 15543535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic evaluation of solid-phase microextraction coatings for untargeted metabolomic profiling of biological fluids by liquid chromatography-mass spectrometry.
    Vuckovic D; Pawliszyn J
    Anal Chem; 2011 Mar; 83(6):1944-54. PubMed ID: 21332182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of free flow electrophoresis to the analysis of the urine proteome.
    Foucher AL; Craft DR; Gelfand CA
    Methods Mol Biol; 2010; 641():27-45. PubMed ID: 20407940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample treatments prior to capillary electrophoresis-mass spectrometry.
    Hernández-Borges J; Borges-Miquel TM; Rodríguez-Delgado MA; Cifuentes A
    J Chromatogr A; 2007 Jun; 1153(1-2):214-26. PubMed ID: 17098242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine sample preparation and protein profiling by two-dimensional electrophoresis and matrix-assisted laser desorption ionization time of flight mass spectroscopy.
    Zerefos PG; Vlahou A
    Methods Mol Biol; 2008; 428():141-57. PubMed ID: 18287772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Proteomics for the Analysis of Circulating Extracellular Vesicles.
    Barrachina MN; García Á
    Methods Mol Biol; 2021; 2259():13-23. PubMed ID: 33687706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.